Rocket One Inc. Common Stock (RKTO) Expected to Announce Earnings on Wednesday

Rocket One Inc. Common Stock (NASDAQ:RKTO) is expected to release its results after the market closes on Wednesday, September 2nd. Analysts expect the company to announce earnings of ($0.1424) per share for the quarter.

Rocket One Inc. Common Stock (NASDAQ:RKTO) last released its quarterly earnings data on Friday, August 14th. The company reported ($0.19) earnings per share for the quarter.

Rocket One Inc. Common Stock Price Performance

Shares of NASDAQ RKTO opened at $0.71 on Monday. The company has a 50-day moving average price of $0.83 and a 200-day moving average price of $0.90. The stock has a market capitalization of $15.84 million, a P/E ratio of -0.87 and a beta of 0.96. Rocket One Inc. Common Stock has a 1 year low of $0.49 and a 1 year high of $2.45.

Institutional Trading of Rocket One Inc. Common Stock

Several institutional investors and hedge funds have recently made changes to their positions in the company. DRW Securities LLC purchased a new position in Rocket One Inc. Common Stock during the fourth quarter worth about $257,000. Citadel Advisors LLC purchased a new stake in Rocket One Inc. Common Stock in the 3rd quarter valued at about $232,000. Virtu Financial LLC purchased a new stake in Rocket One Inc. Common Stock in the 3rd quarter valued at about $184,000. Kestra Private Wealth Services LLC purchased a new stake in Rocket One Inc. Common Stock in the 3rd quarter valued at about $51,000. Finally, Geode Capital Management LLC lifted its position in shares of Rocket One Inc. Common Stock by 18.0% during the 4th quarter. Geode Capital Management LLC now owns 181,112 shares of the company’s stock worth $179,000 after buying an additional 27,577 shares in the last quarter. Hedge funds and other institutional investors own 7.08% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Wall Street Zen cut shares of Rocket One Inc. Common Stock from a “sell” rating to a “strong sell” rating in a research report on Sunday, August 16th. Weiss Ratings raised Rocket One Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 19th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $5.00.

About Rocket One Inc. Common Stock

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.